Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to PET ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Vascular inflammation imaging in psoriasis.Curr Cardiovasc Imaging Rep. 2017; 10: 4
- Systemic effects of inflammation on health during chronic HIV infection.Immunity. 2013; 39: 633-645
- Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.N Engl J Med. 1997; 336: 973-979
- Monocyte and macrophage heterogeneity.Nat Rev Immunol. 2005; 5: 953-964
- Monocyte heterogeneity in obesity and subclinical atherosclerosis.Eur Heart J. 2010; 31: 369-376
- Systemic inflammation and cardiovascular comorbidity in psoriasis patients: causes and consequences.Front Immunol. 2018; 9: 579
- Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: a new concept.Nucl Med Biol. 2006; 33: 1037-1043
- Imaging atherosclerosis with positron emission tomography.Eur Heart J. 2016; 37: 2974-2980
- Role of 18F-FDG PET/CT in the diagnosis of inflammatory and infectious vascular disease.Nucl Med Rev Cent East Eur. 2016; 19: 28-36
- Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time?.J Am Coll Cardiol. 2010; 55: 2527-2535
- Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina.JACC Cardiovasc Imaging. 2010; 3: 388-397
- 18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors.Semin Nucl Med. 2002; 32: 70-76
- Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.Circulation. 2002; 105: 2708-2711
- Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET).Eur J Vasc Endovasc Surg. 2009; 37: 714-721
- Investigating vulnerable atheroma using combined (18)F-FDG PET/CT angiography of carotid plaque with immunohistochemical validation.J Nucl Med. 2011; 52: 1698-1703
- Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology.Circ Cardiovasc Imaging. 2012; 5: 69-77
- Growing applications of FDG PET-CT imaging in non-oncologic conditions.J Biomed Res. 2015; 29: 189-202
- Role of PET/CT in the evaluation of aortic disease.Chonnam Med J. 2018; 54: 143-152
- F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection.Br Med Bull. 2016; 120: 55-74
- Position paper of the cardiovascular committee of the European association of nuclear medicine (EANM) on PET imaging of atherosclerosis.Eur J Nucl Med Mol Imaging. 2016; 43: 780-792
- Unraveling vascular inflammation: from immunology to imaging.J Am Coll Cardiol. 2017; 70: 1403-1412
- Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus.JCI Insight. 2018; 3 ([pii:99276])
- Association between skin and aortic vascular inflammation in patients with psoriasis: a case-cohort study using positron emission tomography/computed tomography.JAMA Cardiol. 2017; 2: 1013-1018
- Arterial inflammation detected with (18) F-Fluorodeoxyglucose-Positron emission tomography in rheumatoid arthritis.Arthritis Rheumatol. 2018; 70: 30-39
- 18FDG PET-CT imaging detects arterial inflammation and early atherosclerosis in HIV-infected adults with cardiovascular disease risk factors.J Inflamm (Lond). 2012; 9: 26
- Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study.Arch Dermatol. 2011; 147: 1031-1039
- Severity of psoriasis associates with aortic vascular inflammation detected by FDG PET/CT and neutrophil activation in a prospective observational study.Arterioscler Thromb Vasc Biol. 2015; 35: 2667-2676
- Complementarity between F-18-FDG PET/CT and ultrasonography or angiography in carotid plaque characterization.J Clin Neurol. 2013; 9: 176-185
- Carotid plaque inflammation imaged by (18)F-fluorodeoxyglucose positron emission tomography and risk of early recurrent stroke.Stroke. 2019; 50: 1766-1773
- Association between aortic vascular inflammation and coronary artery plaque characteristics in psoriasis.JAMA Cardiol. 2018; 3: 949-956
- Coronary plaque morphology and the anti-inflammatory impact of atorvastatin: a multicenter 18F- fluorodeoxyglucose positron emission tomographic/computed tomographic study.Circ Cardiovasc Imaging. 2016; 9 ([pii:e004195])
- Diet-modulated lipoprotein metabolism and vascular inflammation evaluated by (18)F-fluorodeoxyglucose positron emission tomography.Nutrients. 2018; 10: 1382
- Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.J Am Coll Cardiol. 2013; 62: 909-917
- Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study.Arthritis Res Ther. 2018; 20: 171
- Effect of 2 psoriasis treatments on vascular inflammation and novel inflammatory cardiovascular biomarkers: a randomized placebo-controlled trial.Circ Cardiovasc Imaging. 2018; 11: e007394
- A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial).Journal of Investigative Dermatology. 2020; 140 (85-93.e2)
- Risks of cardiovascular disease in patients receiving antiretroviral therapy for HIV infection: implications for treatment.AIDS Read. 2004; 14 (93-5): 86-90
- Prevalence, challenges, and solutions for (18)F-FDG PET studies of obese patients: a technologist's perspective.J Nucl Med Technol. 2007; 35: 80-83
- Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels.Eur J Nucl Med Mol Imaging. 2014; 41: 369-383
- Update on time-of-flight PET imaging.J Nucl Med. 2015; 56: 98-105
- Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet.AJR Am J Roentgenol. 2008; 190: W151-W156
Article info
Footnotes
Funding: None.
Identification
Copyright
Published by Elsevier Inc.
